Cornerstone Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cornerstone Advisory's LLY Position: Q3 2026 in Review
Cornerstone Advisory increased its Eli Lilly (LLY) stake by 1.1% in Q3 2026, buying an estimated $35.4K and bringing the position to 2,881 shares worth $3.33M. The position accounts for 0.26% of the portfolio, ranked #65.
Cornerstone Advisory first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.42M in Q2 2026. 2,903 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cornerstone Advisory held 2,881 shares of Eli Lilly worth $3.33M as of Q3 2026.
- Cornerstone Advisory bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
- Eli Lilly made up 0.26% of Cornerstone Advisory's portfolio in Q3 2026, its #65 holding.
- Cornerstone Advisory first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
- Cornerstone Advisory's Eli Lilly position peaked at $3.42M in Q2 2026.
- 2,903 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cornerstone Advisory's 13F filing for Q3 2026, filed 6 Nov 2026.